Publications by authors named "John Gerich"

Claim this Profile
R
Renal glucose metabolism in normal physiological conditions and in diabetes.
Mazen Alsahli, John E Gerich

Diabetes Res Clin Pract· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
COMMENTARY ON FASTING VERSUS POSTPRANDIAL HYPERGLYCEMIA AS A TREATMENT TARGET TO LOWER ELEVATED A1C.
John G Gerich

Endocr Pract· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia in Patients with Diabetes and Renal Disease.
Mazen Alsahli, John E Gerich

J Clin Med· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lixisenatide in elderly (≥65 years old) and very elderly (≥75 years old) patients with type 2 diabetes: an analysis from the GetGoal phase III programme.
Denis Raccah, Patrick Miossec, Virginie Esposito, Elisabeth Niemoeller, Meehyung Cho, John Gerich

Diabetes Metab Res Rev· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia, chronic kidney disease, and diabetes mellitus.
Mazen Alsahli, John E Gerich

Mayo Clin Proc· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 inhibitors in the treatment of type 2 diabetes.
Farhad M Hasan, Mazen Alsahli, John E Gerich

Diabetes Res Clin Pract· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoglycemia.
Mazen Alsahli, John E Gerich

Endocrinol Metab Clin North Am· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathogenesis and management of postprandial hyperglycemia: role of incretin-based therapies.
John Gerich

Int J Gen Med· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X).
Julio Rosenstock, Denis Raccah, László Korányi, Laura Maffei, Gabor Boka, John E Gerich

Diabetes Care· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.
Crystal A Gadegbeku, Arachelvi Dhandayuthapani, Timothy P Taylor, Zakarea Shrayyef, John Gerich

J Am Soc Hypertens· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glycemic control in the metabolic syndrome and implications in preventing cardiovascular disease.
John E Gerich

Metab Syndr Relat Disord· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono).
Vivian A Fonseca, Ricardo Alvarado-Ruiz, Denis Raccah, Gabor Boka, Patrick Miossec, John E Gerich

Diabetes Care· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of the sodium-glucose co-transporter 2 inhibitor dapagliflozin for the treatment of patients with type 2 diabetes mellitus.
John E Gerich, Arnaud Bastien

Expert Rev Clin Pharmacol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DPP-4 inhibitors: what may be the clinical differentiators?
John Gerich

Diabetes Res Clin Pract· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk.
Ajikumar V Aryangat, John E Gerich

Vasc Health Risk Manag· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus and gastric emptying: questions and issues in clinical practice.
Melvin Samsom, Adil Bharucha, John E Gerich, Kathrin Herrmann, Jörg Limmer

Diabetes Metab Res Rev· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD).
Bernard Zinman, John Gerich, John B Buse, Andrew Lewin, Sherwyn Schwartz

Diabetes Care· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is a history of gestational diabetes related to risk factors for coronary heart disease?
Kathleen B King, John E Gerich, David S Guzick, Kathleen U King, Michael P McDermott

Res Nurs Health· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Different pathophysiology of impaired glucose tolerance in first-degree relatives of individuals with type 2 diabetes mellitus.
Peter Emerson, Timon W Van Haeften, Walkyria Pimenta, Elena Plummer, Hans J Woerle, John Gerich

Metabolism· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide.
Hans J Woerle, Max Albrecht, Rainer Linke, Silvia Zschau, Christoph Neumann, John E Gerich

Diabetes Care· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2 diabetes mellitus is associated with multiple cardiometabolic risk factors.
John E Gerich

Clin Cornerstone· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guideline for management of postmeal glucose.
Antonio Ceriello, Stephen Colagiuri, John Gerich, Jaakko Tuomilehto,

Nutr Metab Cardiovasc Dis· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of aging on glucose homeostasis: accelerated deterioration of beta-cell function in individuals with impaired glucose tolerance.
Ervin Szoke, Muhammad Z Shrayyef, Susan Messing, Hans J Woerle, Timon W van Haeften, John E Gerich

Diabetes Care· March 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rationale for paired pre- and postprandial self-monitoring of blood glucose: the role of glycemic variability in micro- and macrovascular risk.
John E Gerich, Masato Odawara, Yasuo Terauchi

Curr Med Res Opin· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications.
Beth Elaine Dunning, John E Gerich

Endocr Rev· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis